India’s largest drugmaker by market share, Sun Pharmaceutical Industries Ltd, has said that the IT security incident it faced earlier in March will impact the revenues of some of its businesses. The i
TO READ THE FULL STORY, SUBSCRIBE NOW NOW AT JUST RS 249 A MONTH.
Subscribe To Insights
Key stories on business-standard.com are available to premium subscribers only.Already a BS Premium subscriber? Log in NOW
Or